Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 138.90
Bid: 138.80
Ask: 139.30
Change: 5.70 (4.28%)
Spread: 0.50 (0.36%)
Open: 133.00
High: 153.00
Low: 133.00
Prev. Close: 133.20
AML Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Stabilisation Notice

3 Oct 2018 07:00

RNS Number : 7670C
Goldman Sachs International
03 October 2018
 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Aston Martin Lagonda Global Holdings plc

Stabilisation Notice

03 October 2018

Goldman Sachs International hereby gives notice that the entity undertaking stabilisation (the "Stabilisation Manager" named below and its affiliates) may stabilise the offer of the following securities in accordance with Regulation (EU) No 596/2014 (Market Abuse Regulation) and Commission Delegated Regulation (EU) 2016/1052. Stabilisation transactions aim at supporting the market price of the Securities during the Stabilisation Period. Stabilisation may not necessarily occur and it may cease at any time.

The securities:

Issuer:

Aston Martin Lagonda Global Holdings plc

Securities:

Ordinary registered shares ("ORDs" or "Ordinary Shares") of the Issuer (ISIN: GB00BFXZC448)

Offering size:

 57,000,723 Ordinary Shares (excluding the over-allotment option)

Offer Price:

GBP19.00

Stabilisation:

Stabilisation Manager (and central point within the meaning of Commission Delegated Regulation (EU) 2016/1052):

Goldman Sachs International, Peterborough Court, 133 Fleet Street, London EC4A 2BB

Contact: John Bentinck; telephone: +44 (0)20 7774 3408

Beginning of the Stabilisation Period:

03 October 2018

Stabilisation Period to end no later than:

02 November 2018

Trading venue where stabilisation may be undertaken:

London Stock Exchange ("LSE"), BATS, Chi-X

Over-allotment & Greenshoe Option:

Terms:

In connection with the offering (the "Offer"), the Stabilisation Manager, or any of its agents, may (but will be under no obligation to), to the extent permitted by applicable law, over-allot Ordinary Shares sold in the Offer (the "Offer Shares") or effect other stabilisation transactions with a view to supporting the market price of the Offer Shares at a level higher than that which might otherwise prevail in the open market pursuant to an over-allotment option granted to it in connection with the Offer (the "Over-allotment Option"). The Stabilisation Manager is not required to enter into such transactions and such transactions may be effected on any securities market, over-the-counter market, stock exchange or otherwise and may be undertaken at any time during the period commencing on the date of the commencement of conditional dealings in the Offer Shares on the LSE and ending no later than 30 calendar days thereafter. There will be no obligation on the Stabilisation Manager or any of its agents to effect stabilising transactions and there is no assurance that stabilising transactions will be undertaken. Such stabilisation, if commenced, may be discontinued at any time without prior notice. In no event will measures be taken to stabilise the market price of the Offer Shares above £19.00 per Offer Share. Except as required by law or regulation, neither the Stabilisation Manager nor any of its agents intends to disclose the extent of any over-allotments made and/or stabilisation transactions conducted in relation to the Offer.

In connection with the Offer, the Stabilisation Manager may, for stabilisation purposes, over-allot Offer Shares up to a maximum of 10% of the total number of Offer Shares comprised in the Offer.

The Over-allotment Option is exercisable in whole or in part, upon notice by the Stabilisation Manager, at any time on or before the 30th calendar day after the commencement of conditional dealings in the Offer Shares on the LSE. Any Over-allotment Shares made available pursuant to the Over-allotment Option will rank pari passu in all respects with all other Ordinary Shares, including for all dividends and other distributions declared, made or paid on the Ordinary Shares, will be purchased on the same terms and conditions as the Offer Shares being issued or sold in the Offer and will form a single class for all purposes with the other Ordinary Shares.

Number of shares covered by Over-allotment Option:

5,700,072 Ordinary Shares

Duration:

This option may be executed at any time during the Stabilisation Period.

 

 

 

Disclaimer

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilisation Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time.

 

This announcement is for information only and does not constitute an offer or invitation to underwrite, subscribe for or otherwise acquire or dispose of any securities or investment advice in any jurisdiction in which such an offer or solicitation is unlawful, including without limitation, the United States, Australia, Canada, or Japan. Any failure to comply with these restrictions may constitute a violation of the securities laws of such jurisdictions.

 

This announcement and the information contained herein, is not an offer of securities for sale in, and is not for transmission to or publication, distribution or release, directly or indirectly, in the United States of America (including its territories and possessions, any state of the United States of America and the District of Columbia) (the "United States"). The securities being offered have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act"), or under any applicable securities laws of any state or other jurisdiction of the United States and may not be offered, sold, resold, transferred or delivered, directly or indirectly, in the United States unless registered under the Securities Act or pursuant to an exemption from, or in a transaction not subject to, such registration requirements and in accordance with any applicable securities laws of any state or other jurisdiction of the United States. No public offering of the securities discussed herein is being made in the United States.

 

This announcement is directed only at: (A) persons in member states of the European Economic Area (the "EEA") who are "qualified investors" within the meaning of Article 2(1)(e) of the EU Prospectus Directive (Directive 2003/71/EC (and amendments thereto, including Directive 2010/73/EU, to the extent implemented in the relevant member state of the EEA) and includes any relevant implementing measure in each relevant member state of the EEA) (the "Qualified Investors"); (B) in the United Kingdom, Qualified Investors who are persons who (i) have professional experience in matters relating to investments and who fall within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the "Order"); or (ii) are high net worth entities falling within Article 49 of the Order; or (iii) are persons to whom it may otherwise be lawfully communicated. If you are not a person to whom this announcement is directed as set out in (A) and (B) above, you will not be eligible to participate in the offering, and you should not act upon, or rely on, this announcement.

 

END

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STAUGGGCUUPRPUP
Date   Source Headline
30th May 202310:44 amRNSHolding(s) in Company
30th May 202310:39 amRNSHolding(s) in Company
30th May 20238:46 amRNSDirector/PDMR Shareholding
30th May 20238:31 amRNSDirector/PDMR Shareholding
26th May 20239:30 amRNSLTIP and Deferred Bonus Awards
26th May 20239:00 amRNSIssue of Equity and PDMR share awards
26th May 20237:00 amRNSAdmission of New Shares and Total Voting Rights
25th May 20233:05 pmRNSListing Application
18th May 20237:07 amRNSSubstantial Investment in Aston Martin by Geely
17th May 202312:26 pmRNSVoting results of Annual General Meeting
3rd May 20232:37 pmRNSESEF Annual Report
3rd May 20237:00 amRNSQ1 2023 financial results
13th Apr 20239:45 amRNSNotice of AGM
13th Apr 20237:00 amRNSResignation of Non-executive Director
20th Mar 20238:00 amRNSAnnual Financial Report
2nd Mar 20231:01 pmRNSDirector/PDMR Shareholding
1st Mar 20237:00 amRNSFinal Results
23rd Dec 202210:58 amRNSHolding(s) in Company
20th Dec 20223:46 pmRNSDirector/PDMR Shareholding
20th Dec 20228:30 amRNSHolding(s) in Company
15th Dec 20228:00 amRNSHolding(s) in Company
12th Dec 202212:37 pmRNSHolding(s) in Company
22nd Nov 20229:12 amRNSHolding(s) in Company
11th Nov 20228:30 amRNSDirector/PDMR Shareholding
11th Nov 20228:30 amRNSDirector/PDMR Shareholding
11th Nov 20228:30 amRNSHolding(s) in Company
9th Nov 20223:33 pmRNSDirector/PDMR Shareholding
8th Nov 20228:30 amRNSDirector/PDMR Shareholding
8th Nov 20228:30 amRNSDirector/PDMR Shareholding
8th Nov 20228:30 amRNSHolding(s) in Company
3rd Nov 20222:33 pmRNSDirector/PDMR Shareholding
2nd Nov 20227:00 amRNS3rd Quarter Results
1st Nov 20227:00 amRNSDirectorate Change
10th Oct 20221:55 pmRNSResults and Settlement of Tender Offer
30th Sep 20223:59 pmRNSHolding(s) in Company
30th Sep 20223:57 pmRNSDirector/PDMR Shareholding
30th Sep 20223:52 pmRNSDirector/PDMR Shareholding
30th Sep 20223:43 pmRNSDirector/PDMR Shareholding
30th Sep 20229:00 amRNSDirector/PDMR Shareholding
30th Sep 20229:00 amRNSDirector/PDMR Shareholding
30th Sep 20229:00 amRNSDirector/PDMR Shareholding
30th Sep 20227:03 amRNSSuccessful completion of £654m capital raise
30th Sep 20227:00 amRNSHolding(s) in Company
29th Sep 20224:00 pmRNSAppointment of Non-executive Director
29th Sep 20223:05 pmRNSDirector/PDMR Shareholding
29th Sep 20221:36 pmRNSHolding(s) in Company
29th Sep 20228:37 amRNSTender offer for portion of outstanding notes
28th Sep 202212:01 pmRNSRump Placing Announcement
28th Sep 20227:00 amRNSResults of Rights Issue and Total Voting Rights
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.